Guardant Health
GH
#2441
Rank
โ‚น515.79 B
Marketcap
โ‚น4,175
Share price
2.43%
Change (1 day)
127.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -โ‚น403.00

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น425.96. In 2022 the company made an earnings per share (EPS) of -โ‚น555.23 a decrease over its 2021 EPS that were of -โ‚น347.02.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น403.00-27.42%
2022-โ‚น555.2360%
2021-โ‚น347.0255.04%
2020-โ‚น223.83207.14%
2019-โ‚น72.87-19.81%
2018-โ‚น90.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น418.15-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.36-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA